STATEMENT OF BENEFICIAL OWNERSHIP

Company

Marker Therapeutics, Inc.

Filed

February 14, 2000

Accession Number

0000912282-00-000063

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →